IRLAB Therapeutics (Sweden) Probability of Future Stock Price Finishing Under 3.22
| IRLAB-A Stock | SEK 3.47 0.08 2.36% |
IRLAB |
IRLAB Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IRLAB Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IRLAB Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IRLAB Therapeutics generated a negative expected return over the last 90 days | |
| IRLAB Therapeutics has high historical volatility and very poor performance | |
| About 39.0% of the company shares are held by company insiders |
IRLAB Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IRLAB Stock often depends not only on the future outlook of the current and potential IRLAB Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IRLAB Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 401.9 M |
IRLAB Therapeutics Technical Analysis
IRLAB Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. IRLAB Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of IRLAB Therapeutics AB. In general, you should focus on analyzing IRLAB Stock price patterns and their correlations with different microeconomic environments and drivers.
IRLAB Therapeutics Predictive Forecast Models
IRLAB Therapeutics' time-series forecasting models is one of many IRLAB Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary IRLAB Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about IRLAB Therapeutics
Checking the ongoing alerts about IRLAB Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for IRLAB Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| IRLAB Therapeutics generated a negative expected return over the last 90 days | |
| IRLAB Therapeutics has high historical volatility and very poor performance | |
| About 39.0% of the company shares are held by company insiders |
Other Information on Investing in IRLAB Stock
IRLAB Therapeutics financial ratios help investors to determine whether IRLAB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IRLAB with respect to the benefits of owning IRLAB Therapeutics security.